Barbara Mantelli

Barbara Mantelli

Auto-generated profile, based on publicly available information

Barbara Mantelli

Department of Molecular Medicine, University of Padova, Padova, Italy

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Immunobiology
Verified
Journal Article
Open access
EPElisa Peranzoni
Elisa Peranzoni
IMIlaria Marigo
Ilaria Marigo
LDLuigi Dolcetti
Luigi Dolcetti
SUStefano Ugel
Stefano Ugel
NSNada Sonda
Nada Sonda
PZPaola Zanovello
Paola Zanovello
A heterogeneous set of cells that are commonly grouped as "myeloid cells", interacts in a complex landscape of physiological and pathological situations. In this review we attempt to trace a profile of the "myeloid connection" through different normal and pathological states, by analyzing common metabolic pathways of the amino acid l-arginine. Myeloid cells exert various, often divergent, actions on the immune response through mechanisms that exploit mediators of this peculiar metabolic pathway, ranging from l-arginine itself to its downstream metabolites, like nitric oxide and polyamines. Various pathological situations, including neoplastic and autoimmune diseases, as well as injury repair and infections are discussed here, showing how l-arginine metabolism is able to play a dual role, both as an active protector and a possible threat to the organism.

1 August 2008 in Cancer Letters
Verified
Journal Article
Closed access
LDLuigi Dolcetti
Luigi Dolcetti
IMIlaria Marigo
Ilaria Marigo
BMBarbara Mantelli
Barbara Mantelli
EPElisa Peranzoni
Elisa Peranzoni
PZPaola Zanovello
Paola Zanovello
VBVincenzo Bronte
Vincenzo Bronte

10 November 2015 in Scientific Reports
Verified
Journal Article
Open access
PDF file
VDVito Giuseppe D’aGostino
Vito Giuseppe D’aGostino
PLPreet Lal
Preet Lal
BMBarbara Mantelli
Barbara Mantelli
CTChristopher Tiedje
Christopher Tiedje
CZChiara Zucal
Chiara Zucal
APAlessandro Provenzani
Alessandro Provenzani
Post-transcriptional regulation is an essential determinant of gene expression programs in physiological and pathological conditions. HuR is a RNA-binding protein that orchestrates the stabilization and translation of mRNAs, critical in inflammation and tumor progression, including tumor necrosis factor-alpha (TNF). We identified the low molecular weight compound 15,16-dihydrotanshinone-I (DHTS), well known in traditional Chinese medicine practice, through a validated high throughput screening on a set of anti-inflammatory agents for its ability to prevent HuR:RNA complex formation. We found that DHTS interferes with the association step between HuR and the RNA with an equilibrium dissociation constant in the nanomolar rangein vitro(Ki = 3.74 ± 1.63 nM). In breast cancer cell lines, short term exposure to DHTS influences mRNA stability and translational efficiency of TNF in a HuR-dependent manner and also other functional readouts of its post-transcriptional control, such as the stability of selected pre-mRNAs. Importantly, we show that migration and sensitivity of breast cancer cells to DHTS are modulated by HuR expression, indicating that HuR is among the preferential intracellular targets of DHTS. Here, we disclose a previously unrecognized molecular mechanism exerted by DHTS, opening new perspectives to therapeutically target the HuR mediated, post-transcriptional control in inflammation and cancer cells.

4 May 2015 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
CZChiara Zucal
Chiara Zucal
VDVito Giuseppe D'Agostino
Vito Giuseppe D'Agostino
RLRosa Loffredo
Rosa Loffredo
BMBarbara Mantelli
Barbara Mantelli
NTNatthakan Thongon
Natthakan Thongon
APAlessandro Provenzani
Alessandro Provenzani
The RNA-binding protein (RBP) HuR is one of the most widely studied regulators of the eukaryotic posttranscriptional gene expression and it plays a physiological role in mediating the cellular response to apoptotic, proliferating and survival stimuli. Following physiological or stress stimuli, HuR protein binds to Adenylate-Urydinilate rich elements (AREs) generally contained in the 3’UTR of transcripts, then it shuttles from the nucleus to the cytoplasm and regulates the half-life and/or translation of cargo mRNAs. Derangements in sub-cellular localization and expression of HuR have been associated with the pathophysiology of many diseases and this protein has been proposed as a potential drug target. Recent findings also re-evaluated HuR as a splicing and polyadenylation factor, expanding its spectrum of functional activity up to the maturation of pre-mRNAs. In this review, we generate a comprehensive picture of HuR functionality to discuss the implications of considering HuR as pharmacological target and the detrimental or positive impact that can be expected upon its modulation. Firstly, we focus on the recent findings about the mechanistic role of HuR in the nucleus and in the regulation of long non coding RNAs; then we describe the animal models and the clinical association and significance in cancer; finally, we have reviewed the pharmacological tools that influence HuR’s post-transcriptional control and the efforts made to identify specific HuR inhibitors.

1 June 2003 in Blood
Verified
Journal Article
Closed access
PDF file
PBPriscilla Biswas
Priscilla Biswas
BMBarbara Mantelli
Barbara Mantelli
ASAntonio Sica
Antonio Sica
MMMauro Malnati
Mauro Malnati
CPCarla Panzeri
Carla Panzeri
ABAlberto Beretta
Alberto Beretta
CD4, the primary receptor for entry of HIV, is known to be expressed on T cells and monocytes/macrophages; healthy natural killer (NK) lymphocytes; in vitro human herpesvirus 6 (HHV6)–infected CD8+, NK, and γδ T lymphocytes; CD34+ progenitor cells; and a subset of eosinophils and basophils. We here report the unconventional expression of CD4 at the surface of peripheral blood neutrophils derived from 4 of 51 (7.8%) HIV-1–infected and 3 of 25 (12%) uninfected donors, with similar frequency within the 2 groups. The percentage of CD4+ neutrophils ranged from 39% to 97% of the total neutrophil population. Both surface and cytoplasmic forms of CD4 were present in neutrophils. Quantitative RNA polymerase chain reaction (PCR) revealed that neutrophils contain levels of CD4 mRNA comparable to those of peripheral blood mononuclear cells derived from the same donor. The conformation of CD4 expressed at the surface of neutrophils was similar to that of CD4 expressed on T lymphocytes as determined by the binding of monoclonal antibodies specific for conformational epitopes and the binding of recombinant HIV-1 gp120. Thus, our data provide evidence that neutrophils express endogenous CD4 and bind HIV. Owing to their abundance in peripheral blood, CD4+ neutrophils may influence significantly the biodistribution of HIV delivering it to sites of inflammation or to additional tissue reservoirs.

1 January 1999 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
CBChiara Bovolenta
Chiara Bovolenta
ALAlessandro L Lorini
Alessandro L Lorini
BMBarbara Mantelli
Barbara Mantelli
LCLaura Camorali
Laura Camorali
FNFrancesco Novelli
Francesco Novelli
GPGuido Poli
Guido Poli
IFN-γ induces transcription of several IFN-stimulated genes (ISGs). Recently, the IFN-γ-dependent Janus kinase (JAK)/STAT pathway has been shown to mediate the activation of some ISGs, by the sequential phosphorylation of two JAK kinases (JAK1 and JAK2) and of STAT1. Given that the JAK/STAT is the major, but not the only pathway linked to the IFN-γR, aim of our work was to investigate the signal-transduction pathway(s) by which IFN-γ exerts its effects on acute replication of HIV in monocytic cells. To this end, we utilized clones previously derived from the U937 promonocytic cell line, differing for their efficient (plus clones) or inefficient (minus clones) abilities of supporting HIV replication. Unlike IFN-α, IFN-γ did not inhibit HIV replication in plus clones, whereas virus production in minus cells was efficiently inhibited by both types of IFN. Plus clones generated a JAK/STAT signal-transduction pathway in response to IFN-α, but not IFN-γ. In contrast, minus clones responded to either cytokines. The functional defect of plus clones in response to IFN-γ was correlated to a selective defect of IFN-γR2, but not IFN-γR1, membrane expression. Surprisingly enough, IFN-γ stimulation of plus clones induced IFN-stimulated gene factor 3 (ISGF3γ). These results strongly support the hypothesis that the JAK/STAT pathway is responsible for the antiretroviral effect of IFN-γ, and further provide evidence for a potential second pathway triggered by IFN-γ in the absence of IFN-γR2 chain cell surface expression and involving ISGF3γ.